Helix Clinical Research has announced a partnership with Southern Illinois Associates to expand mental health clinical trials in the Metro East area. This collaboration aims to improve access to mental health treatments and enhance the quality of clinical research.
Currently, the Metro East region faces challenges in mental health care accessibility. Many residents lack sufficient options for treatment, which can lead to untreated conditions and poor outcomes. By increasing the number of clinical trials available, Helix and Southern Illinois Associates aim to provide more opportunities for individuals to participate in cutting-edge research that may lead to new therapies.
The initiative will focus on several areas of mental health, including depression and anxiety disorders. Participants in the trials will have the chance to receive new treatments that are not yet available to the general public, potentially improving their mental health outcomes.
In addition to benefiting participants, these trials will generate valuable data that can inform future mental health treatments and policies. Helix Clinical Research plans to enroll a diverse group of participants, ensuring that the research reflects the varied demographics of the region.
This partnership marks a step forward in addressing the mental health needs of the Metro East community, providing both immediate access to care and contributing to long-term advancements in treatment options.
German 
English 
French 
Russian 
Spanish 
Belarusian 
Ukrainian